The store will not work correctly when cookies are disabled.
4'-Fluoro-2-(fluorosulfonyl)biphenyl-4-carboxylic acid
ID: ALA4524407
PubChem CID: 145946042
Max Phase: Preclinical
Molecular Formula: C13H8F2O4S
Molecular Weight: 298.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1ccc(-c2ccc(F)cc2)c(S(=O)(=O)F)c1
Standard InChI: InChI=1S/C13H8F2O4S/c14-10-4-1-8(2-5-10)11-6-3-9(13(16)17)7-12(11)20(15,18)19/h1-7H,(H,16,17)
Standard InChI Key: HNGNJNXHCQAHBJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
4.2923 -15.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8878 -14.9942 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.4789 -15.6974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6004 -13.7684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5993 -14.5879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3073 -14.9969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0170 -14.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0142 -13.7648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3056 -13.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3090 -15.8119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5996 -16.2197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5990 -17.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3072 -17.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0173 -17.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0144 -16.2179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3027 -12.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0092 -12.1279 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5937 -12.1321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3081 -18.2629 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1839 -14.5868 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
6 10 1 0
16 17 1 0
16 18 2 0
9 16 1 0
13 19 1 0
5 2 1 0
2 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.27 | Molecular Weight (Monoisotopic): 298.0111 | AlogP: 2.85 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.44 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.79 | CX Basic pKa: ┄ | CX LogP: 3.08 | CX LogD: -0.19 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -0.63 |
References
1. Mukherjee H, Su N, Belmonte MA, Hargreaves D, Patel J, Tentarelli S, Aquila B, Grimster NP.. (2019) Discovery and optimization of covalent Bcl-xL antagonists., 29 (23): [PMID:31606346] [10.1016/j.bmcl.2019.126682] |